Jason M Johnson Selected Research

Jason M Johnson Research Topics

Disease

17	Neoplasms (Cancer) 04/2024 - 01/2017
8	Head and Neck Neoplasms (Head and Neck Cancer) 12/2022 - 09/2018
6	Squamous Cell Carcinoma of Head and Neck 01/2023 - 11/2018
4	Glioma (Gliomas) 04/2024 - 01/2019
2	Breast Neoplasms (Breast Cancer) 11/2021 - 01/2016
2	Pain (Aches) 01/2019 - 01/2018
1	Glioblastoma (Glioblastoma Multiforme) 08/2023
1	Disease Progression 07/2023
1	Hydrocephalus (Hydrocephaly) 02/2023
1	Breast Diseases (Breast Disease) 11/2021
1	Brain Neoplasms (Brain Tumor) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Ependymoma 01/2020
1	Oropharyngeal Neoplasms 01/2020
1	Medulloblastoma 01/2020
1	Sarcoidosis (Schaumann Disease) 11/2019
1	Nausea 01/2019
1	Residual Neoplasm 01/2019
1	Fatty Liver 01/2019
1	Turcot syndrome 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2019
1	Necrosis 11/2018
1	Edema (Dropsy) 11/2018
1	Inflammation (Inflammations) 11/2018
1	Circulating Neoplastic Cells 09/2018
1	Laryngeal Neoplasms (Laryngeal Cancer) 01/2018
1	Meningioma (Meningiomas) 01/2018
1	Obesity 01/2018
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 07/2010
1	Stroke (Strokes) 11/2009
1	Frostbite 11/2009
1	Cysts 07/2009
1	Sclerosis 07/2009
1	Hypersensitivity (Allergy) 06/2009
1	Hernia (Hernias) 03/2009
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2009
1	Aneurysm (Aneurysms) 09/2008
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2008
1	Schizophrenia (Dementia Praecox) 08/2007

Drug/Important Bio-Agent (IBA)

3	Immune Checkpoint InhibitorsIBA 11/2020 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 11/2020
2	Contrast MediaIBA 01/2021 - 11/2018
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2007
2	Amino Acids FDA Link 01/2019 - 11/2018
1	dipinacoline glutamateIBA 07/2023
1	cemiplimabIBA 01/2023
1	Unithiol (DMPS)IBA 01/2023
1	Phosphotransferases (Kinase)IBA 12/2022
1	Reticulin (Reticular Fiber)IBA 01/2022
1	CollagenIBA 11/2021
1	ferric oxide (iron oxide)IBA 01/2021
1	GadoliniumIBA 01/2021
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 01/2021
1	durvalumabIBA 01/2020
1	tremelimumabIBA 01/2020
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 01/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 11/2019
1	RadiopharmaceuticalsIBA 01/2019
1	Desflurane (I 653)FDA Link 01/2019
1	fluciclovine F-18IBA 01/2019
1	Complement System Proteins (Complement)IBA 11/2018
1	Edetic Acid (EDTA)FDA Link 09/2018
1	Gallium-68IBA 01/2018
1	gallium Ga 68 dotatateIBA 01/2018
1	Opioid Analgesics (Opioids)IBA 01/2018
1	LigandsIBA 01/2018
1	Morphine (MS Contin)FDA LinkGeneric 01/2018
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2018
1	Indicators and Reagents (Reagents)IBA 01/2016
1	Tumor Biomarkers (Tumor Markers)IBA 01/2016
1	Small Nucleolar RNA (snoRNA)IBA 07/2010
1	PapaverineIBA 11/2009
1	MicroRNAs (MicroRNA)IBA 11/2009
1	Ethanol (Ethyl Alcohol)IBA 07/2009
1	Nucleosomes (Nucleosome)IBA 06/2009
1	Deoxyribonucleases (DNase)FDA Link 06/2009
1	Polypropylenes (Polypropylene)IBA 03/2009
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2009
1	Malonyl Coenzyme A (Malonyl CoA)IBA 01/2009
1	Acetyl Coenzyme A (Acetyl-CoA)IBA 01/2009
1	LDL CholesterolIBA 05/2008

Therapy/Procedure

14	Radiotherapy 04/2024 - 01/2017
5	Therapeutics 07/2023 - 11/2009
4	Drug Therapy (Chemotherapy) 12/2022 - 11/2018
4	Immunotherapy 12/2022 - 01/2019
3	Bariatric Surgery 01/2019 - 12/2006
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 03/2006 - 11/2005
1	Precision Medicine 08/2023
1	Ventriculoperitoneal Shunt 02/2023
1	Re-Irradiation 04/2020
1	Intraventricular Infusions 01/2020
1	Gastrectomy 01/2019
1	Intravenous Anesthesia 01/2019
1	Anesthesia 01/2019
1	Secondary Prevention 11/2018
1	Aftercare (After-Treatment) 11/2018
1	Pain Management 01/2018
1	Laryngectomy 01/2017
1	Laparotomy 09/2008